Microbiome Therapeutic Innovation Group

To represent and promote the voice of the common business interest of microbiome therapeutics and microbiome-based products to provide guidance and related policies used to seek regulatory clarity on issues including clinical trials designs, endpoint selections, and evidential burdens.